Overview

Efficacy and Safety Study of Topical Capsaicin in Painful Diabetic Neuropathy

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
Painful diabetic neuropathy is the most common cause of neuropathic pain. 0.075% topical capsaicin has been used to treat the pain, but there is no data in lower concentration. This is the efficacy and safety of 0.025% topical capsaicin in treatment of painful diabetic polyneuropathy.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Thammasat University
Collaborator:
Bangkok Drug company
Treatments:
Capsaicin